Clinical Trial Update: AMIStem Primary Hip System Prospective Post-marketing Multi-centre Surveillance Study [NA]

View source ↗

Summary

This Clinical Trial Update describes a post-marketing, multi-centre surveillance study of the AMIStem Primary Hip System sponsored by Medacta International SA. …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arthritis
• Avascular Necrosis
• Congenital Hip Dysplasia
• Fracture of the Femoral Head
• Fracture of the Femoral Neck
• Osteoarthritis

Drugs mentioned

• AMIStem Primary Hip System

Snippet

Sponsor: Medacta International SA | Conditions: Osteoarthritis, Arthritis | NA | Status: ACTIVE_NOT_RECRUITING